These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 29340699)

  • 1. Long-term expression of glomerular genes in diabetic nephropathy.
    Chittka D; Banas B; Lennartz L; Putz FJ; Eidenschink K; Beck S; Stempfl T; Moehle C; Reichelt-Wurm S; Banas MC
    Nephrol Dial Transplant; 2018 Sep; 33(9):1533-1544. PubMed ID: 29340699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carnosine Attenuates the Development of both Type 2 Diabetes and Diabetic Nephropathy in BTBR ob/ob Mice.
    Albrecht T; Schilperoort M; Zhang S; Braun JD; Qiu J; Rodriguez A; Pastene DO; Krämer BK; Köppel H; Baelde H; de Heer E; Anna Altomare A; Regazzoni L; Denisi A; Aldini G; van den Born J; Yard BA; Hauske SJ
    Sci Rep; 2017 Mar; 7():44492. PubMed ID: 28281693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glomerular expression pattern of long non-coding RNAs in the type 2 diabetes mellitus BTBR mouse model.
    Reichelt-Wurm S; Wirtz T; Chittka D; Lindenmeyer M; Reichelt RM; Beck S; Politis P; Charonis A; Kretz M; Huber TB; Liu S; Banas B; Banas MC
    Sci Rep; 2019 Jul; 9(1):9765. PubMed ID: 31278342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological PAR-1 inhibition reduces blood glucose levels but does not improve kidney function in experimental type 2 diabetic nephropathy.
    Waasdorp M; Florquin S; Duitman J; Spek CA
    FASEB J; 2019 Oct; 33(10):10966-10972. PubMed ID: 31287960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-Cell RNA Profiling of Glomerular Cells Shows Dynamic Changes in Experimental Diabetic Kidney Disease.
    Fu J; Akat KM; Sun Z; Zhang W; Schlondorff D; Liu Z; Tuschl T; Lee K; He JC
    J Am Soc Nephrol; 2019 Apr; 30(4):533-545. PubMed ID: 30846559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-cell transcriptomics reveals a mechanosensitive injury signaling pathway in early diabetic nephropathy.
    Liu S; Zhao Y; Lu S; Zhang T; Lindenmeyer MT; Nair V; Gies SE; Wu G; Nelson RG; Czogalla J; Aypek H; Zielinski S; Liao Z; Schaper M; Fermin D; Cohen CD; Delic D; Krebs CF; Grahammer F; Wiech T; Kretzler M; Meyer-Schwesinger C; Bonn S; Huber TB
    Genome Med; 2023 Jan; 15(1):2. PubMed ID: 36627643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Grem2 mediates podocyte apoptosis in high glucose milieu.
    Wen H; Kumar V; Mishra A; Song S; Aslam R; Hussain A; Wang H; Zhou X; He X; Wu G; Luo H; Lan X; Malhotra A; Singhal PC
    Biochimie; 2019 May; 160():113-121. PubMed ID: 30831151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The SGLT2 inhibitor empagliflozin ameliorates early features of diabetic nephropathy in BTBR ob/ob type 2 diabetic mice with and without hypertension.
    Gembardt F; Bartaun C; Jarzebska N; Mayoux E; Todorov VT; Hohenstein B; Hugo C
    Am J Physiol Renal Physiol; 2014 Aug; 307(3):F317-25. PubMed ID: 24944269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BTBR Ob/Ob mutant mice model progressive diabetic nephropathy.
    Hudkins KL; Pichaiwong W; Wietecha T; Kowalewska J; Banas MC; Spencer MW; Mühlfeld A; Koelling M; Pippin JW; Shankland SJ; Askari B; Rabaglia ME; Keller MP; Attie AD; Alpers CE
    J Am Soc Nephrol; 2010 Sep; 21(9):1533-42. PubMed ID: 20634301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temporal expression profile and distribution pattern indicate a role of connective tissue growth factor (CTGF/CCN-2) in diabetic nephropathy in mice.
    Roestenberg P; van Nieuwenhoven FA; Joles JA; Trischberger C; Martens PP; Oliver N; Aten J; Höppener JW; Goldschmeding R
    Am J Physiol Renal Physiol; 2006 Jun; 290(6):F1344-54. PubMed ID: 16380465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LRG1 Promotes Diabetic Kidney Disease Progression by Enhancing TGF-
    Hong Q; Zhang L; Fu J; Verghese DA; Chauhan K; Nadkarni GN; Li Z; Ju W; Kretzler M; Cai GY; Chen XM; D'Agati VD; Coca SG; Schlondorff D; He JC; Lee K
    J Am Soc Nephrol; 2019 Apr; 30(4):546-562. PubMed ID: 30858225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of CP-900691, a novel peroxisome proliferator-activated receptor α, agonist on diabetic nephropathy in the BTBR ob/ob mouse.
    Askari B; Wietecha T; Hudkins KL; Fox EJ; O'Brien KD; Kim J; Nguyen TQ; Alpers CE
    Lab Invest; 2014 Aug; 94(8):851-62. PubMed ID: 24955894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PLVAP as an Early Marker of Glomerular Endothelial Damage in Mice with Diabetic Kidney Disease.
    Wolf EE; Steglich A; Kessel F; Kröger H; Sradnick J; Reichelt-Wurm S; Eidenschink K; Banas MC; Wolf E; Wanke R; Gembardt F; Todorov VT
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic Analysis of Obesity-Induced Diabetic Nephropathy in BTBR Mice.
    Keller MP; O'Connor C; Bitzer M; Schueler KL; Stapleton DS; Emfinger CH; Broman AT; Hodgin JB; Attie AD
    Diabetes; 2024 Feb; 73(2):312-317. PubMed ID: 37935024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carnosinase-1 overexpression, but not aerobic exercise training, affects the development of diabetic nephropathy in BTBR
    Everaert I; He J; Hanssens M; Stautemas J; Bakker K; Albrecht T; Zhang S; Van der Stede T; Vanhove K; Hoetker D; Howsam M; Tessier FJ; Yard B; Baba SP; Baelde HJ; Derave W
    Am J Physiol Renal Physiol; 2020 Apr; 318(4):F1030-F1040. PubMed ID: 32150446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human carnosinase 1 overexpression aggravates diabetes and renal impairment in BTBR
    Qiu J; Albrecht T; Zhang S; Hauske SJ; Rodriguez-Niño A; Zhang X; Nosan D; Pastene DO; Sticht C; Delatorre C; van Goor H; Porubsky S; Krämer BK; Yard BA
    J Mol Med (Berl); 2020 Sep; 98(9):1333-1346. PubMed ID: 32803273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pyruvate kinase M2 activation may protect against the progression of diabetic glomerular pathology and mitochondrial dysfunction.
    Qi W; Keenan HA; Li Q; Ishikado A; Kannt A; Sadowski T; Yorek MA; Wu IH; Lockhart S; Coppey LJ; Pfenninger A; Liew CW; Qiang G; Burkart AM; Hastings S; Pober D; Cahill C; Niewczas MA; Israelsen WJ; Tinsley L; Stillman IE; Amenta PS; Feener EP; Vander Heiden MG; Stanton RC; King GL
    Nat Med; 2017 Jun; 23(6):753-762. PubMed ID: 28436957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered vitamin D metabolism in type II diabetic mouse glomeruli may provide protection from diabetic nephropathy.
    Wang Y; Zhou J; Minto AW; Hack BK; Alexander JJ; Haas M; Li YC; Heilig CW; Quigg RJ
    Kidney Int; 2006 Sep; 70(5):882-91. PubMed ID: 16820793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Automated image analysis of a glomerular injury marker desmin in spontaneously diabetic Torii rats treated with losartan.
    Kakimoto T; Okada K; Hirohashi Y; Relator R; Kawai M; Iguchi T; Fujitaka K; Nishio M; Kato T; Fukunari A; Utsumi H
    J Endocrinol; 2014 Jul; 222(1):43-51. PubMed ID: 24781258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection of CTGF Antibody Against Diabetic Nephropathy in Mice Via Reducing Glomerular β-Catenin Expression and Podocyte Epithelial-Mesenchymal Transition.
    Dai HY; Ma LN; Cao Y; Chen XL; Shi H; Fan YP; Yang B
    J Cell Biochem; 2017 Nov; 118(11):3706-3712. PubMed ID: 28370212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.